An audit of Colposcopy referrals from a GU/STD clinic

被引：4

作者：

O'Connor C. ^{[1
]}

Myles H. ^{[2
]}

O'Connor M.B. ^{[2
]}

Clancy J. ^{[1
]}

Ryan A. ^{[1
]}

Traynor M. ^{[1
]}

McGrath D. ^{[1
]}

O'Sullivan K. ^{[1
]}

机构：

[1] Dept of GU/STD Medicine, Mid-Western Regional Hospital, Limerick

[2] School of Medicine, University College, Cork

来源：

BMC Research Notes | / 1卷 / 1期

关键词：

Cervical Cancer; Chlamydia Trachomatis; Sexual Debut; High Grade Lesion; Cervical Smear;

D O I：

10.1186/1756-0500-1-24

中图分类号：

学科分类号：

摘要：

Background. Cervical cancer is increasing at 1.5% per year in Ireland with 50% mortality giving 2.2% of all cancer deaths. In the Mid-West region a pilot screening programme has begun to screen all women 25-60 years. 66% of Genitourinary/Sexually transmitted disease (GU/STD) clinics' abnormal smears are <25 years. Requests to abandon "opportunistic" screening prompted this GU/STD clinic audit. Methods. 221(8.4%) patients referred to colposcopy over 4 years were audited. Retrospective analysis was carried out on GU/STD clinic files, hospital files and computer records for biopsy reports. Ethical approval was prospectively granted. Results. 2637 smears were carried out from November 1999 - September 2003. 221 patients referred to colposcopy were audited. 1%, 3%, 5% had severe, moderate and, mild dyskaryosis, respectively, on cervical screening while 0.8%, 1.2%, 1.5% had CIN3, CIN2, CIN1 abnormalities, respectively, on biopsy with 3.5% having no abnormality (Cervical Intraepithelial Neoplasia = CIN). 53% referred to colposcopy were <25 years. Conclusion. 2% had high grade lesions. 37% of high grade lesions are <25 years. Of the high grade lesions 13% had Chlamydia trachomatis (27% of CIN3) and 44% had HPV despite Relative Risks (RR) being 0.75 and 1.09 respectively. Older women had higher grade changes. No statistical difference was found for progression, regression and persistence in those over and under 25. © 2008 O'Connor et al; licensee BioMed Central Ltd.

引用

共 27 条

[1]

Yang B.H., Bray F.I., Parkin D.M., Sellors J.W., Zhang Z.F., Cervical cancer as a priority for prevention in different world regions: An evaluation using years of life lost, Int J Cancer, 109, 3, pp. 418-24, (2004)

[2]

Comber H., Gavin A., Recent trends in cervical cancer mortality in Britain and Ireland: The case for population-based cervical cancer screening, Br J Cancer, 91, 11, pp. 1902-4

[3]

National Cancer Register, Ireland

[4]

McCaffery K., Waller J., Forrest S., Cadman L., Szarewski A., Wardle J., Testing positive for human papillomavirus in routine cervical screening: Examination of psychosocial impact, BJOG, 111, 12, (2004)

[5]

Foley E., Harindra V., Cervical cytology: Are national guidelines adequate for women attending genitourinary medicine clinics?, Sex Transm Infect, 75, pp. 349-51, (1999)

[6]

MacGregor J.E., Teper S., Uterine cervical cytology and young women, Lancet, 2, pp. 1029-31, (1978)

[7]

Treanor D., Magee D., Turner L., Carroll B., Gibbons D., Incidence of cervical dyskaryosis in Ireland: Report of a 5 year audit, IMJ, 95, 7, pp. 206-8, (2002)

[8]

Treacy A., Lyons F., Mulcahy F., Opportunistic cervical screening at a sexual health clinic, Ir Med J, 99, 7, pp. 198-9, (2006)

[9]

Wilson J.D., Parsons W., Cervical cytology smears in sexually transmitted infection clinics in the United Kingdom, Sexually Transmitted Infections, 77, 2, pp. 107-110, (2001)

[10]

Orr Jr. J.W., Barrett J.M., Orr P.F., Holloway R.W., Holimon J.L., The efficacy and safety of the cytobrush during pregnancy, Gynecol Oncol, 44, 3, pp. 260-2, (1992)

← 1 2 3 →